Author Archive for: johanna-butler
About Johanna Butler
Johanna Butler joined NASHP’s Coverage, Cost, and Value team in June 2018. She is involved with several projects related to lowering the cost of health care, focusing specifically on health system costs and prescription drug prices. She has also worked on advancing evidence-based policymaking through patient-centered outcomes research. Prior to joining NASHP, Johanna was an intern in the ranking member’s health policy office of the Senate Committee on Health, Education, Labor, and Pensions. She has also worked as the Lloyd Meeds Policy Fellow at K&L Gates and interned in the White House Office of Cabinet Affairs. Johanna graduated from American University in 2018 with an interdisciplinary studies degree focused on communications, law, economics, and government, and holds a certificate in Advanced Leadership Studies from the School of Public Affairs.
Entries by Johanna Butler
State Drug Price Transparency Programs Identify Critical Data on High Cost Drugs
April 25, 2022 in Policy, Prescription Drug Pricing Maine, Oregon, Washington Blogs, Featured News Home Prescription Drug Pricing /by Johanna Butler and Jennifer ReckStates’ drug price transparency programs are effectively analyzing and reporting data — an important tool for informing the public, holding drug supply chain entities accountable for high costs, and identifying potential policy approaches. Leading states are highlighting high prices for anti-inflammatory drugs, the impact of pharmacy benefit manager (PBM) regulation on drug spending and the […]
Massachusetts Health Policy Commission Takes Steps to Hold High-Cost Health System Accountable
February 14, 2022 in Health System Costs Massachusetts Blogs, Featured News Home Cost, Payment, and Delivery Reform, Health System Costs /by Johanna ButlerIn January, for the first time in its history, the Massachusetts Health Policy Commission (HPC)’s Board voted to require the Mass General Brigham (MGB) health system to submit a Performance Improvement Plan (PIP) because of the system’s substantial contributions to the state’s health care cost increases. The HPC’s comprehensive analysis of MGB cost data and […]
Drug Price Transparency Laws Position States to Impact Drug Prices
January 10, 2022 in Prescription Drug Pricing California, Maine, Nevada, Oregon, Vermont Blogs, Featured News Home Prescription Drug Pricing /by Johanna Butler and Jennifer ReckDrug price transparency laws enable state policymakers to understand opaque drug pricing and payment systems to formulate appropriate policy solutions to high prices, while also creating the data infrastructure to effectively realize those policy solutions. Since Vermont passed the first state drug price transparency law in 2016, more than a dozen states have enacted and […]
Opportunities for Aligning Prescription Drug Affordability Boards and Cost-Growth Benchmarks
November 15, 2021 in Prescription Drug Pricing Blogs Prescription Drug Pricing /by Johanna ButlerHigh prices for health care services and prescription drugs are driving health care spending and increasing insurance premiums. To tackle rising health care costs, states have advanced two separate but related initiatives over the past few years: cost-growth benchmarks to track and contain overall health care spending; and prescription drug affordability boards (PDABs) to conduct […]
Leveraging State Insurance Commissioners’ Authority to Lower Hospital Costs
June 29, 2021 in Health System Costs Blogs, Featured News Home /by Johanna ButlerFacing rising health care costs and increased consolidation of hospitals and provider groups into large health systems, states are exploring ways to contain costs and provide oversight of the growing market power of large hospitals. Through model policies from the National Academy for State Health Policy (NASHP), states can leverage their existing health market authority […]
Sign Up for Our Weekly Newsletter
Sign Up for Our Weekly Newsletter
Washington, DC Office:
1233 20th St., N.W., Suite 303Washington, DC 20036
p: (202) 903-0101
f: (202) 903-2790
Contact Us
Phone: 202-903-0101

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































